Jonathan Hannay
Impact in
- Oncology top 10%
- Vascular Tumors and Angiosarcomas
- Biotechnology top 10%
- Cancer Research and Treatments
Papers in
-
- Sarcoma Diagnosis and Treatment 9
- Biliary and Gastrointestinal Fistulas 2
- Oncology 8
- Vascular Tumors and Angiosarcomas 5
- Cancer-related Molecular Pathways 2
- Co-authors
- Raphael E. Pollock (8 shared papers)Dihua Yu (7 shared papers)Dina Lev (5 shared papers)Juehui Liu (3 shared papers)Lianglin Zhang (2 shared papers)Daniel J. Hicklin (2 shared papers)Svetlana Bolshakov (2 shared papers)Alexander J. Lazar (2 shared papers)
- Journals
- Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)BMC Nephrology (1 paper)British journal of surgery (1 paper)Expert Review of Anticancer Therapy (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Jonathan Hannay
16 papers receiving 744 citations
Peers
Comparison fields: 5 of 80
- Oncology 263
- Biotechnology 66
- Physiology 185
- Cancer Research 100
- Molecular Biology 431
Countries citing papers authored by Jonathan Hannay
This map shows the geographic impact of Jonathan Hannay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Hannay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Hannay more than expected).
Fields of papers citing papers by Jonathan Hannay
This network shows the impact of papers produced by Jonathan Hannay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Hannay. The network helps show where Jonathan Hannay may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Hannay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 230 | |
| 2 | 2007 | 104 | |
| 3 | Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis. | 2002 | 75 |
| 4 | 2006 | 65 | |
| 5 | 2008 | 59 | |
| 6 | 2006 | 53 | |
| 7 | 2004 | 47 | |
| 8 | 2015 | 37 | |
| 9 | 2014 | 21 | |
| 10 | 2007 | 14 | |
| 11 | 2013 | 14 | |
| 12 | 2013 | 13 | |
| 13 | 1985 | 12 | |
| 14 | 2017 | 7 | |
| 15 | 2022 | 3 | |
| 16 | 2016 | 2 | |
| 17 | 2020 | 0 |
About Jonathan Hannay
Jonathan Hannay is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 17 papers that have together received 756 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (9 papers), Vascular Tumors and Angiosarcomas (5 papers), Virus-based gene therapy research (2 papers), Gastrointestinal disorders and treatments (2 papers), Cancer-related Molecular Pathways (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Cardiac tumors and thrombi (2 papers) and Biliary and Gastrointestinal Fistulas (2 papers). The work is most often cited by research in Oncology (263 citations), Biotechnology (66 citations), Physiology (185 citations), Cancer Research (100 citations) and Molecular Biology (431 citations). Jonathan Hannay has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Raphael E. Pollock, Dihua Yu, Dina Lev, Juehui Liu, Lianglin Zhang, Daniel J. Hicklin, Svetlana Bolshakov, Alexander J. Lazar, Jeremy D. Henson and David Jellinek. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, BMC Nephrology, British journal of surgery and Expert Review of Anticancer Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.